Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ZTS

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today

Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 11.89% on an annualized basis producing an average annual return of 20.56%. Currently, Zoetis has a market capitalization of $75.58 billion.

Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years

Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years

Zoetis (NYSE:ZTS) has outperformed the market over the past 5 years by 10.79% on an annualized basis producing an average annual return of 21.83%. Currently, Zoetis has a market capitalization of $79.47 billion.

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX Laboratories (IDXX) should benefit. But the stocks of which of these two companies is a better buy now? Read on to learn our…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Buy These 3 Battered Stocks Before They Rebound

Worries over the Federal Reserve’s aggressive monetary policy tightening have driven an intense sell-off in the stock market of late. As a result, many quality stocks have fallen into oversold territory. Given this backdrop, we think it could be wise to scoop up the beaten-down stocks of fundamentally sound companies…

Zoetis Corrals A First-Quarter Beat, But Gives Its 2022 Outlook A Shave

Zoetis beat first-quarter expectations Thursday and ZTS stock rose higher despite the company's unexpected guidance cut.

Investors Business Daily

3 Pet Stocks to Buy and Hold in 2022

Despite rising pet care costs amid the Russia-Ukraine war and record-high inflation, the demand for pet care products remains strong. And because a significant increase in pet ownership amid the COVID-19 pandemic is expected to keep the demand high, we think it could be wise to scoop up shares of…

Add These 4 No-Brainer Stocks Down More than 20% to Your Portfolio

Due to the increasing sanctions on Russia, inflationary pressures, and supply chain disruptions, the stock market has been exhibiting high volatility. However, quality stocks Zoetis (ZTS), Accenture (ACN), Micron Technology (MU), and QUALCOMM (QCOM), which declined more than 20% year-to-date, have the potential to rebound quickly. So, these stocks could…

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Beaten-Down Growth Stocks With More Than 50% Upside Potential

3 Beaten-Down Growth Stocks With More Than 50% Upside Potential

The key to taking advantage of the bear market in growth stocks is to look for companies whose earnings momentum and growth are unaffected by changes in economic or monetary conditions. Therefore, investors should consider buying the following 3 high-quality growth stocks: Veeva Systems (VEEV), Resmed, Inc. (RMD), and Zoetis…

Zoetis's Return On Capital Employed Insights

Zoetis's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Zoetis (NYSE:ZTS) posted Q4 earnings of $413.00 million, an increase from Q3 of 25.18%. Sales dropped to $1.97 billion, a 1.16% decrease between quarters.

2 Beaten-Down Pet Stocks Worth Buying Right Now

2 Beaten-Down Pet Stocks Worth Buying Right Now

Pet ownership has skyrocketed during the COVID-19 pandemic, driving the demand for medications, pet food, and other pet-related services. So, beaten-down pet stocks Zoetis (ZTS) and IDEXX Laboratories (IDXX) could bounce back in the near term because the demand for pet-related products and services is expected to grow. So, let’s…

Zoetis Tops Quarterly Forecasts As Spot And Fluffy Contribute To Sales Growth

Zoetis Tops Quarterly Forecasts As Spot And Fluffy Contribute To Sales Growth

Animal-health player Zoetis topped fourth-quarter expectations on Tuesday, leading ZTS stock to rise in early action.

Investors Business Daily

Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook

Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook

Zoetis Inc (NYSE: ZTS) has reported Q4 FY21 revenue of $2 b

4 Top Dividend Growth Stocks to Add to Your Watchlist

4 Top Dividend Growth Stocks to Add to Your Watchlist

Dividend investing is an effective way of generating income with limited concern about market volatility. So, investors looking to assure a consistent flow of income, along with capital appreciation, could consider adding quality dividend stocks Microsoft (MSFT), Eli Lilly (LLY), Zoetis (ZTS), and The TJX (TJX) to their watchlists. These…

Better Buy for 2022: Zoetis vs. Zomedica

Better Buy for 2022: Zoetis vs. Zomedica

Rising pet ownership and increasing focus on animal health have boosted the demand for animal healthcare solutions. Therefore, Zoetis (ZTS) and Zomedica (ZOM) should benefit. But which of these two stocks is a better buy now? Read more to find out.

Get all your
news in one place.

100’s of premium titles.
One news app.

4 Growth Stocks to Buy on the Dip

Amid the current, inflationary environment, the Fed’s recent signal that it will raise interest rates aggressively precipitated a huge market sell-off last week. However, fundamentally sound growth stocks Anthem (ANTM), Zoetis (ZTS), Moderna (MRNA), and Forrester Research (FORR), which witnessed moderate corrections, could rebound soon. So, we think it could…

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Micron Technology Inc

IDEXX Laboratories

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Monetary Policy

Places

249,789 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play